TSS:Hg 187102.1

Basic information about the TSS

---

TSS ID: hg_187102.1 Species: human Chr: chr20		Start: 35954294 End: 35954356 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: KJ898876 EU446495 AB464702 AM392883 AM393129 CR457188 Distance: 11 GeneID: 51282 HGNC/MGI_ID: HGNC:10566 UniProt_ID:

Gene_name: SCAN domain containing 1 Gene_symbol: SCAND1 Gene_synonyms: RAZ1 SDP1 Gene_source: HGNC:10566

TATA-Box annotation

---

Distance to TSS:	301
Nearest PromoterID:	NM_033630
Entrez ID:	51282
Nearest Unigene:	Hs.584909
Nearest Refseq:	NM_016558
Nearest Ensembl:	ENSG00000171222
Gene Name:	SCAN domain containing 1
Gene Alias:	RAZ1
Gene Description:	SCAN domain containing 1
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.671642
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SCAND1 p2@SCAND1 p3@SCAND1 p4@SCAND1 p5@SCAND1 p6@SCAND1 p7@SCAND1
Sample		p1@SCAND1	p2@SCAND1	p3@SCAND1	p4@SCAND1	p5@SCAND1	p6@SCAND1	p7@SCAND1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	46.75	56.69	2.34	1.36	4.29	1.56	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	57.05	67.78	2.43	1.21	2.23	2.23	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	49.77	64.62	2.70	1.35	2.70	4.44	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	50.94	70.07	2.91	1.66	3.33	3.53	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.02	64.34	2.92	2.02	3.15	3.60	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	45.93	58.34	1.94	1.16	2.91	3.49	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	57.74	94.13	3.05	2.40	3.05	4.14	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	51.83	88.17	5.33	1.94	5.57	5.33	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	59.63	95.96	4.70	2.14	3.42	4.70	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	44.63	132.73	8.11	0.58	7.54	4.06	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	59.42	140.67	6.06	1.21	7.68	6.47	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.84	140.26	8.94	0.41	6.50	6.10	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	55.13	63.03	2.10	1.29	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	44.95	50.22	2.26	0.90	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	47.64	52.47	1.76	1.32	0.66	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	47.78	63.12	2.51	1.76	1.01	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.90	53.29	2.40	0.66	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	43.45	49.77	1.69	1.69	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	54.38	44.78	0.53	0.53	1.07	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	55.36	64.99	2.86	1.65	0.90	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	50.52	61.21	3.21	1.74	0.94	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	52.82	67.67	2.07	1.38	0.86	0.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.82	51.19	1.55	1.03	0.26	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.65	55.33	2.67	0.49	0.97	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	45.66	66.05	2.84	0.77	0.26	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	63.94	67.10	3.48	3.48	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	50.55	57.14	0.55	0.00	0.00	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.80	61.30	2.36	1.18	0.94	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	61.38	61.70	3.07	2.91	0.97	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.97	50.85	1.81	2.53	0.90	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	57.15	68.46	2.51	2.09	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	58.81	76.20	3.52	1.37	1.95	1.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	50.86	60.99	2.74	2.53	1.69	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	58.72	57.23	1.65	1.32	0.99	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	51.42	69.75	5.42	0.75	0.93	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	55.38	64.19	2.68	0.57	0.77	1.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	54.77	78.07	4.09	1.84	1.23	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	50.77	61.05	3.43	1.81	0.81	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	56.99	75.09	3.51	0.81	1.08	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	49.45	71.54	4.08	0.96	1.20	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	45.41	70.58	4.47	1.65	0.24	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	48.60	62.36	1.76	2.20	1.02	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	47.66	66.22	2.53	1.69	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	56.99	71.33	2.62	2.45	0.52	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	59.43	69.27	4.22	0.60	1.61	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.56	62.58	1.16	1.86	0.23	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	56.62	73.17	2.64	1.20	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	61.99	82.56	3.87	1.19	1.19	1.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	73.01	67.50	3.35	1.91	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	64.10	66.32	2.83	2.22	0.81	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	61.49	53.90	2.87	2.66	1.64	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	68.49	73.83	4.45	2.22	0.67	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	41.98	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	61.75	55.36	5.68	2.84	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	68.93	59.65	4.31	2.32	1.33	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.13	10.91	3.36	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	48.22	39.04	2.76	2.30	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	59.64	63.85	2.59	1.30	0.32	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	59.74	47.53	3.21	1.28	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	46.21	40.55	2.51	0.94	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	54.29	28.91	1.41	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	52.71	35.89	2.24	2.80	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	15.13	0.00	0.00	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	44.17	31.60	0.34	1.02	0.34	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	57.19	46.46	0.97	0.32	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.47	37.63	2.48	1.06	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.59	17.06	0.98	0.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	38.68	20.33	0.00	1.49	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	16.89	2.35	0.94	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	25.50	21.20	0.66	1.32	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	36.50	18.87	1.55	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.27	20.48	2.45	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	43.71	28.51	1.74	1.90	0.95	0.63	0.00
Adipocyte - breast, donor2	11327-117E4	29.68	27.59	1.44	1.12	0.48	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	31.04	21.37	2.16	1.15	0.00	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	38.12	26.91	2.24	3.74	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	48.90	25.79	2.68	1.34	1.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	53.59	22.33	2.55	3.83	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	42.88	49.48	1.10	0.00	1.10	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.68	10.84	1.35	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.49	28.50	1.56	1.39	1.39	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	29.92	15.25	1.76	1.17	0.78	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	28.05	20.33	2.83	1.54	0.51	1.03	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	33.45	27.32	1.12	1.67	1.12	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	22.92	3.53	1.18	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	36.28	28.31	1.77	1.69	0.56	0.48	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	29.05	21.30	2.26	0.65	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	25.59	21.86	3.20	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	38.39	23.93	0.56	1.11	1.67	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	34.10	45.75	3.33	2.50	0.00	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	31.14	23.86	1.26	1.51	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	38.29	35.02	0.65	0.98	0.33	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	33.19	0.61	0.91	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	41.77	25.64	1.77	0.88	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	80.68	69.56	5.38	2.87	1.79	2.51	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	16.77	1.20	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	18.89	22.31	2.52	0.54	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	51.88	36.82	1.67	5.02	3.35	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.52	24.45	1.03	1.64	0.62	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	41.54	36.16	0.69	2.29	0.34	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	40.16	41.63	2.20	0.98	1.22	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	19.77	24.71	0.00	1.80	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.09	22.58	0.87	0.87	1.74	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	49.23	36.38	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	23.32	19.73	0.30	1.49	0.60	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	35.41	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	40.92	40.26	0.66	1.98	1.32	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.32	21.12	1.62	0.32	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.87	26.70	0.97	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.82	33.26	1.78	0.59	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	22.97	0.75	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.12	21.77	0.73	1.45	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	46.39	30.09	1.25	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	27.02	21.09	0.66	1.81	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	19.11	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.02	37.25	1.51	1.81	0.60	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	23.04	37.51	0.54	2.68	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	29.47	25.70	0.94	1.89	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	35.55	33.68	0.80	0.80	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	24.39	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.53	24.38	1.00	1.00	0.50	1.49	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	37.22	1.20	4.80	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	24.78	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.01	19.73	1.37	1.03	0.69	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	20.97	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	27.67	22.33	1.46	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.39	25.80	1.52	0.76	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	47.24	36.34	1.21	3.63	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.07	32.49	1.71	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	28.43	26.51	2.14	0.86	0.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.97	28.65	1.29	3.36	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.21	30.50	0.94	1.88	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	16.40	0.32	1.29	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	27.11	38.53	0.00	2.14	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	25.15	21.06	1.17	1.75	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	33.42	18.67	1.51	1.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	42.77	27.32	2.38	2.38	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	31.02	31.53	1.02	2.03	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.90	19.61	0.51	0.51	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	40.03	32.40	0.64	1.91	0.64	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	26.76	20.71	0.43	0.43	1.29	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.67	22.02	1.69	0.64	0.85	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.70	32.48	1.16	1.45	1.16	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	17.01	1.89	2.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	28.48	23.90	0.68	1.86	0.51	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	32.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	16.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	27.87	26.16	0.64	1.50	1.07	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.70	32.49	0.60	1.80	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	20.41	18.95	2.19	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.64	30.34	1.38	1.15	0.92	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	22.95	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	29.49	42.71	1.53	2.29	0.51	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.46	26.84	1.24	1.65	0.41	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.44	26.93	3.06	1.53	1.22	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	26.29	28.68	1.91	0.96	0.48	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.06	24.17	1.33	0.89	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	33.57	25.94	3.05	3.05	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	26.03	1.66	1.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.95	21.45	2.38	1.59	0.53	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.25	37.07	2.18	1.82	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	59.32	28.98	0.98	2.70	0.61	0.25	0.00
Astrocyte - cerebellum, donor2	11580-120F5	66.07	30.81	1.54	3.08	1.37	1.20	0.00
Astrocyte - cerebellum, donor3	11661-122F5	46.56	41.32	2.52	1.68	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	40.78	33.46	2.44	2.09	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	42.71	30.09	1.94	1.13	0.32	0.97	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	43.11	24.76	1.19	2.39	0.15	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	14.57	26.95	0.34	0.57	0.23	0.23	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	16.29	24.56	1.00	0.50	0.25	0.63	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	15.36	26.86	0.11	0.57	0.34	0.57	0.00
Basophils, donor1	12241-129G9	46.29	40.80	7.06	0.78	1.83	0.26	5.23
Basophils, donor2	12242-129H1	36.08	42.57	5.41	0.00	1.80	0.36	10.46
Basophils, donor3	12243-129H2	34.54	35.57	7.35	0.29	1.62	0.73	1.91
Bronchial Epithelial Cell, donor1	11511-119G8	17.46	26.30	3.02	0.86	0.22	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	53.49	46.63	7.31	0.91	1.37	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	28.69	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	40.80	45.19	6.28	0.00	1.88	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	39.51	29.74	1.25	0.62	0.42	1.87	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	14.97	40.30	3.68	0.46	0.23	0.69	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	14.40	19.43	3.06	0.36	0.36	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.49	28.96	1.44	0.52	1.44	0.62	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	6.75	41.69	0.70	0.47	0.70	0.70	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	124.07	77.39	2.88	7.35	0.64	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	124.10	51.71	10.34	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	29.30	25.36	1.13	0.56	0.56	0.56	2.82
CD14+ Monocytes, donor2	11305-117B9	36.56	20.23	3.90	0.56	1.11	0.56	4.83
CD14+ Monocytes, donor3	11381-118B4	45.44	31.39	5.05	1.32	1.54	0.88	4.61
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	62.55	16.98	0.28	3.11	1.13	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.50	19.33	1.52	2.27	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.42	14.46	0.99	2.63	1.97	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	48.28	26.02	1.88	1.88	2.17	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	40.43	32.89	3.32	1.21	0.91	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	53.30	31.51	2.84	2.61	2.84	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.14	24.61	2.51	0.50	3.52	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.88	22.08	2.76	0.00	2.48	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	32.23	24.79	4.46	0.50	1.24	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	29.76	13.51	0.39	0.59	1.17	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	31.51	22.43	2.49	0.89	1.07	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	33.73	24.59	4.13	0.00	1.31	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.13	18.50	1.40	0.00	1.17	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	23.23	18.48	1.58	0.00	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	17.75	21.08	4.44	3.33	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	33.02	23.20	1.78	1.19	1.78	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.74	22.95	1.20	0.40	1.80	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.68	28.52	2.29	1.46	0.83	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.85	23.79	1.83	0.69	1.37	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.66	25.56	2.49	0.68	1.58	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	26.19	21.82	1.75	0.87	2.18	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	42.77	17.48	1.08	1.61	1.88	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	34.89	31.58	2.09	0.17	1.40	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	55.13	31.14	1.68	1.26	1.68	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	25.72	18.37	1.29	0.73	1.29	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	24.66	19.73	1.41	0.35	1.41	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	33.78	21.50	1.75	1.32	1.75	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.64	20.75	1.57	0.52	1.39	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.27	22.67	1.86	0.37	2.23	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	33.63	27.16	1.94	0.43	0.65	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.29	20.47	0.82	0.41	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.09	18.54	1.85	0.00	0.46	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	21.58	17.40	2.09	0.00	1.86	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	56.23	31.39	3.92	1.96	1.31	0.87	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	53.59	41.58	7.62	2.08	1.39	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	68.45	29.46	3.68	2.82	2.17	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	97.95	41.42	4.36	5.76	1.09	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	64.79	35.10	4.02	1.22	1.75	0.87	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	56.86	27.43	4.46	1.78	1.34	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	84.46	55.37	9.70	2.55	1.28	2.04	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	52.92	51.16	8.78	2.20	1.98	0.88	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	62.53	44.21	3.79	1.68	2.53	0.21	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	115.84	4.06	0.00	0.00	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	34.58	77.29	1.36	0.68	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	98.38	7.25	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	54.90	106.07	10.13	0.53	1.07	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	41.81	123.83	4.29	1.61	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	42.82	96.17	6.32	3.51	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	46.28	100.40	4.71	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	52.73	129.19	5.27	0.00	0.00	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	31.23	142.19	10.68	0.82	2.47	1.64	9.04
CD19+ B Cells, donor2	11624-122B4	26.12	114.62	12.33	0.73	2.90	1.45	4.35
CD19+ B Cells, donor3	11705-123B4	20.19	116.61	11.61	0.00	1.01	0.00	7.07
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.93	35.15	2.42	1.21	0.00	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	63.92	37.55	2.00	0.80	1.60	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	87.35	50.20	3.01	1.00	0.00	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	53.37	58.43	8.99	2.25	2.25	1.12	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	71.77	46.22	2.25	7.14	0.38	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	81.17	53.89	2.03	3.16	1.58	1.58	1.35
CD4+ T Cells, donor1	11225-116C1	40.70	68.91	13.21	0.36	0.71	6.07	14.28
CD4+ T Cells, donor2	11306-117C1	56.95	101.65	22.05	0.00	1.84	2.45	23.27
CD4+ T Cells, donor3	11382-118B5	56.73	85.40	19.21	1.22	4.27	2.74	29.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.70	64.32	1.28	0.51	0.51	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	58.62	73.44	2.02	0.67	1.12	1.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	58.07	86.24	1.15	0.29	0.29	1.72	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	80.12	276.87	39.35	0.95	1.90	4.27	25.60
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	60.40	309.72	25.28	0.00	0.00	2.11	21.07
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	283.48	32.96	0.00	3.30	0.00	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	74.71	89.46	4.62	0.72	0.87	2.02	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	73.72	68.63	2.71	1.69	0.68	1.53	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	72.22	64.80	4.19	0.64	0.97	1.29	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	100.87	132.25	15.69	1.34	1.79	1.34	53.80
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	87.70	142.20	18.17	1.75	1.05	3.14	21.66
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	65.56	81.40	7.92	0.44	0.00	1.32	24.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.53	75.05	2.11	1.69	0.00	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	47.37	67.53	2.08	0.21	0.00	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	56.47	66.16	3.68	1.34	0.33	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	53.57	119.92	12.24	1.63	1.63	2.45	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	157.03	12.86	1.61	0.00	0.54	5.36
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	60.97	147.04	28.69	0.00	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	54.15	64.16	3.15	0.37	0.56	2.04	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	43.54	54.80	3.90	0.87	1.30	0.87	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.95	60.31	2.31	0.84	0.00	1.26	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	73.31	150.67	26.80	2.02	2.53	6.57	32.86
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	66.72	171.13	25.13	1.30	2.60	4.77	30.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	45.32	64.94	14.38	0.00	0.44	1.31	19.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	73.74	111.84	4.95	1.48	0.49	1.48	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	45.24	87.70	0.92	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	76.77	114.46	5.58	0.00	1.40	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	50.40	75.05	3.88	0.55	1.11	0.83	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	48.59	64.54	3.68	0.25	0.49	1.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	63.14	77.00	3.08	0.00	3.08	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	63.03	68.40	5.73	0.36	0.00	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	69.25	92.79	4.15	1.38	1.38	2.77	2.77
CD8+ T Cells, donor1	11226-116C2	36.67	78.90	17.35	0.33	4.58	2.29	40.92
CD8+ T Cells, donor2	11307-117C2	54.44	81.47	23.65	1.13	3.75	4.51	37.17
CD8+ T Cells, donor3	11383-118B6	57.06	94.18	19.95	0.50	4.04	4.80	24.24
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	39.23	68.13	3.21	2.29	0.92	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.30	62.79	3.59	1.68	0.96	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	42.41	70.04	2.46	1.09	1.09	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	35.12	46.23	3.30	1.80	0.90	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	27.36	41.04	2.16	0.72	0.24	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.75	66.17	2.50	1.59	1.14	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.16	56.93	2.39	0.87	1.09	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.79	54.22	1.84	0.53	1.32	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.65	52.30	2.11	1.41	0.47	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.92	68.53	3.92	0.91	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.89	72.05	2.91	0.58	0.58	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	33.57	69.54	3.20	1.07	0.80	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.39	46.40	3.06	0.88	3.50	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.21	56.93	5.47	0.00	2.73	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.93	49.97	5.97	0.00	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	37.82	61.23	2.52	1.08	0.36	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	32.51	63.30	4.60	1.73	1.44	0.29	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.94	50.91	2.36	1.18	1.89	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	22.82	34.86	2.54	0.32	0.63	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	26.76	60.90	1.23	0.92	0.31	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.44	47.45	3.85	0.32	0.00	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.39	48.19	1.53	1.15	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.62	49.66	1.97	0.79	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.18	54.46	1.51	2.27	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	11.24	77.08	10.44	0.00	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	10.49	92.32	6.99	0.00	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	81.14	9.02	1.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	60.32	25.59	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	42.99	36.07	1.48	2.47	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	21.36	15.89	1.26	0.63	0.21	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	19.07	9.01	0.69	0.69	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	45.13	23.81	3.20	2.84	0.71	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	31.86	23.78	1.59	1.48	0.91	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	44.76	16.11	1.79	3.58	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	26.29	20.62	1.62	0.00	1.21	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	40.62	31.67	1.61	1.72	0.92	0.80	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	52.37	35.49	0.86	1.92	0.86	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	37.08	34.34	1.15	1.50	0.80	0.80	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.98	39.71	3.58	1.01	0.18	0.64	0.00
Corneal Epithelial Cells, donor1	11526-119I5	24.37	23.71	2.42	0.88	0.22	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	40.95	42.09	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	23.52	30.68	3.58	0.51	0.00	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.87	17.50	1.32	0.99	0.83	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.01	22.39	1.58	1.26	0.63	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	24.15	3.45	6.90	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.37	15.33	0.76	1.40	0.54	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	106.59	42.02	3.42	2.39	2.39	1.71	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.68	45.05	5.22	4.57	0.65	2.61	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	125.83	60.49	4.84	2.42	1.45	2.90	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	73.55	15.34	0.67	2.67	0.83	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	78.63	21.71	0.00	1.76	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	61.65	13.01	0.57	2.26	0.28	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	84.14	22.02	1.97	1.97	1.18	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	62.25	12.22	1.45	1.16	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	61.41	21.88	0.94	2.12	1.65	1.18	0.00
Endothelial Cells - Artery, donor3	11413-118E9	89.06	18.58	1.93	4.91	1.23	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.01	8.42	0.66	1.11	0.22	1.11	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	27.08	4.87	0.00	0.91	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.94	3.38	0.28	0.85	0.00	0.85	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	44.87	18.72	1.19	2.67	0.59	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	85.91	29.68	2.60	1.56	0.00	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	39.98	13.75	0.71	0.57	0.00	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	49.61	11.60	2.40	2.40	1.60	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	72.85	20.96	1.57	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	54.42	7.45	0.87	2.73	0.37	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	49.75	11.51	0.65	1.52	1.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	59.35	10.38	0.61	2.32	0.49	0.37	0.00
Endothelial Cells - Vein, donor1	11267-116G7	83.04	18.20	1.14	2.28	1.14	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	104.78	24.45	2.10	4.19	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	86.82	21.82	0.94	2.04	1.10	0.79	0.00
Eosinophils, donor1	12244-129H3	45.74	76.23	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	49.51	9.90	0.00	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	32.10	46.37	3.57	0.00	0.00	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	15.39	15.15	1.71	1.22	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	27.04	2.08	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	48.81	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	29.56	22.17	1.23	0.00	0.82	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	44.45	27.48	1.86	1.75	0.55	1.20	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	62.62	56.01	3.03	1.84	0.98	0.76	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.17	17.95	1.21	1.46	0.49	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.88	12.56	0.96	0.96	0.96	0.55	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.31	15.29	1.37	0.42	0.63	0.63	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.55	8.70	1.32	0.79	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.22	20.26	1.99	0.66	0.00	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	47.18	20.87	0.91	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.99	43.20	1.52	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	36.91	26.97	3.00	1.42	0.95	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	23.95	16.67	1.21	1.21	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	32.36	19.67	2.16	1.02	0.38	0.25	0.00
Fibroblast - Cardiac, donor6	11460-119B2	36.99	12.28	0.61	1.21	0.45	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.03	16.88	1.74	1.74	0.00	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.12	25.89	1.73	1.29	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	20.51	0.00	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	16.84	43.36	2.08	1.85	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	26.63	15.60	0.68	0.34	0.34	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	31.23	17.37	0.70	1.88	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	56.13	31.60	0.00	3.30	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	35.06	17.29	1.21	2.42	0.48	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	37.42	12.32	0.68	1.24	0.57	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	39.95	17.27	1.22	1.92	0.52	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	44.99	12.51	0.81	2.44	0.32	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	24.15	15.41	1.04	0.62	0.83	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.95	31.70	1.31	1.57	0.00	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	37.16	15.55	0.53	1.32	0.79	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	20.11	18.27	0.68	0.97	0.68	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	19.74	0.00	0.00	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	38.59	22.03	2.29	0.88	0.88	0.70	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	44.59	24.48	0.62	2.65	1.25	0.31	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	40.57	22.04	1.08	1.89	0.95	0.27	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	58.23	40.93	1.06	3.88	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	46.36	28.23	1.17	2.34	0.58	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	43.50	22.09	0.82	1.77	0.41	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	34.44	18.10	0.66	2.19	0.66	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	55.32	32.87	1.47	3.23	0.59	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	66.61	42.14	1.36	5.44	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	11.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	45.58	21.31	0.84	2.53	0.42	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	39.15	24.99	0.00	1.67	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	36.36	11.19	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	41.42	26.59	1.12	1.96	0.56	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	31.67	18.67	1.62	0.81	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	35.95	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.57	14.35	0.58	3.10	0.58	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	29.12	14.11	0.61	1.52	0.91	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.89	7.96	0.31	1.84	0.31	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.13	18.70	0.38	1.53	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	49.41	24.84	0.81	1.62	1.62	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	47.55	22.38	0.93	1.16	1.39	0.46	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.22	19.45	0.99	1.22	0.99	0.88	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	27.84	19.30	0.20	1.22	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	43.43	23.39	0.00	2.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.79	26.09	1.19	3.95	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.84	7.94	0.79	0.20	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.56	12.97	0.36	0.18	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.04	10.84	0.59	0.39	0.39	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	22.86	6.62	0.30	1.20	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	23.64	10.80	0.76	1.73	0.22	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	19.74	15.44	0.25	1.01	0.76	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	26.09	20.02	0.33	0.66	0.00	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	14.64	10.63	0.40	1.40	0.40	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	21.70	16.27	0.80	0.30	0.10	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.04	15.11	0.30	0.91	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.58	12.43	1.08	0.75	0.25	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	29.57	9.74	0.17	0.51	0.34	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.74	9.20	0.33	0.99	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	20.88	15.77	0.43	0.96	0.21	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	30.36	20.24	0.51	1.35	0.17	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	25.25	15.21	0.47	0.47	0.16	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	27.02	2.61	2.61	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.90	29.99	2.60	1.21	0.17	1.21	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	17.44	17.44	1.30	1.82	0.78	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	17.89	22.74	1.53	0.51	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	140.10	75.79	0.00	8.42	1.53	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	166.54	63.17	3.83	7.02	2.55	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	150.90	25.67	1.14	4.28	0.86	2.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	137.60	73.63	2.21	4.69	0.28	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	71.92	65.53	2.05	4.79	1.60	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	115.11	33.29	0.99	3.96	1.39	1.78	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	116.84	64.76	2.91	6.08	0.79	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	61.32	73.71	2.28	2.28	1.63	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	169.81	20.34	1.33	6.19	2.21	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.15	20.07	1.55	3.11	0.71	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	32.76	21.18	1.23	2.83	0.62	0.86	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.19	20.15	0.81	1.88	0.54	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	25.52	11.27	0.87	0.99	0.00	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.71	12.87	0.42	1.94	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	34.76	13.62	0.41	2.24	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	42.21	19.17	1.14	2.51	0.68	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.50	15.94	0.75	1.87	0.00	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.88	14.64	0.87	2.62	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	52.30	32.21	1.18	1.18	1.48	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.20	23.05	0.79	2.70	0.16	0.95	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.10	16.09	0.67	3.57	0.45	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.41	32.46	1.41	2.82	1.21	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.37	28.50	1.70	2.37	0.00	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.42	21.02	0.80	1.42	0.80	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.65	25.08	1.87	2.08	0.73	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	43.72	26.98	2.90	2.39	0.17	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.20	24.34	1.66	1.66	0.66	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.52	19.22	1.00	1.83	0.25	0.75	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.57	20.42	1.23	0.20	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	36.31	29.09	1.03	2.48	0.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	31.01	23.64	1.04	2.19	0.35	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	44.03	26.68	1.50	1.67	0.50	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	42.54	29.10	0.88	2.42	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	34.93	26.20	1.72	1.60	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	35.82	28.04	0.97	1.62	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.28	25.98	1.92	3.85	0.32	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	37.14	27.19	1.52	2.27	0.09	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.91	26.42	1.27	2.37	0.95	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	38.92	37.10	3.04	2.13	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.33	26.13	1.46	2.20	0.94	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.98	40.40	2.63	0.66	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	31.70	27.21	0.56	1.40	1.12	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.44	39.81	1.85	2.50	0.65	0.93	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.30	43.85	1.07	1.34	1.34	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	36.26	37.95	1.99	1.53	0.46	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.16	32.51	1.42	2.72	0.26	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	30.09	36.59	1.90	1.63	1.08	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.90	39.64	1.47	0.92	0.37	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.48	36.63	2.41	2.85	1.10	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	22.81	0.00	2.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.53	22.69	2.24	0.92	0.53	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.75	26.43	1.41	1.41	0.61	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.74	22.87	1.02	1.27	0.51	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	31.85	7.96	0.20	2.99	0.20	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	30.82	14.95	1.08	1.23	0.92	0.92	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	47.46	17.18	2.86	0.82	0.41	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	150.83	54.14	5.63	5.01	0.31	2.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	151.73	53.40	4.24	4.24	0.28	1.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	84.40	38.28	3.69	3.69	0.00	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	126.21	81.67	4.95	4.95	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	99.02	47.96	2.71	2.32	0.39	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	121.94	59.37	8.02	3.21	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	118.24	48.69	6.96	5.22	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	93.41	47.52	2.60	6.18	0.33	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	92.24	44.89	2.06	4.94	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	26.66	6.66	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.06	45.02	3.64	3.36	0.28	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	83.02	45.43	0.65	2.61	1.31	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	66.27	33.55	0.84	4.19	0.00	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	82.70	40.08	1.59	4.45	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	87.63	37.70	2.38	3.40	0.00	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	114.85	58.47	0.00	4.18	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	90.49	32.07	1.15	4.58	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	83.17	40.25	2.66	3.26	0.59	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	81.32	57.60	6.78	5.08	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	88.23	54.26	3.73	2.07	0.83	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	85.84	59.60	1.84	4.83	0.69	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	89.56	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.35	50.36	3.08	3.84	0.38	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	88.66	49.55	1.96	3.91	0.65	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	110.36	73.57	3.34	3.34	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	76.28	50.08	1.16	5.78	0.39	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	84.90	50.32	1.03	3.08	3.77	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	57.15	37.27	0.00	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	81.16	52.38	4.72	3.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	80.26	54.31	1.21	4.22	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	73.25	61.04	2.54	3.56	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	70.99	47.46	2.39	2.79	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	68.58	41.44	3.45	4.93	0.00	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	75.55	46.04	3.54	7.08	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	85.77	58.34	2.33	4.67	0.58	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	72.85	44.33	1.76	3.95	0.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.01	47.47	0.85	0.85	1.70	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	69.24	53.72	3.58	5.97	0.60	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	79.58	61.63	3.88	3.88	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	67.34	22.83	2.28	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	42.41	24.95	1.25	1.66	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	120.32	37.11	2.25	4.50	0.00	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.06	15.22	1.27	0.95	0.63	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	25.90	2.09	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.62	41.31	2.32	0.70	1.97	1.28	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	30.55	42.88	0.68	1.52	1.52	1.52	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.30	37.31	0.91	0.91	1.82	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	29.84	46.89	2.30	0.44	1.53	1.20	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.72	41.69	1.07	1.07	1.29	1.50	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.68	32.29	1.94	1.94	0.43	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	24.28	39.73	2.74	1.37	2.12	1.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.16	35.68	1.37	1.03	1.03	1.03	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.34	41.01	3.52	0.32	0.32	1.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	73.31	10.63	1.68	1.68	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	56.26	18.18	0.87	3.03	0.43	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	66.10	23.79	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	45.50	25.04	0.71	2.12	1.06	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	58.85	24.70	0.73	2.91	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	35.84	34.79	1.92	1.05	0.35	0.52	0.00
Hepatocyte, donor1	11523-119I2	12.11	76.27	1.21	1.21	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	59.25	61.41	2.15	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	52.76	44.79	2.45	1.84	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	97.90	145.55	3.26	1.96	1.96	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	45.97	58.55	6.64	1.22	0.70	0.70	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.68	13.03	1.10	1.37	0.00	0.55	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	85.97	66.86	3.18	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	33.38	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	59.53	38.76	4.15	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	62.57	65.07	7.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	118.68	35.60	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	56.38	0.00	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	59.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	63.35	50.35	8.12	1.62	8.12	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	30.01	1.67	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	32.68	0.00	0.00	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	55.59	3.97	1.32	0.00	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	43.24	36.59	1.11	3.33	0.00	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	89.05	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	52.28	32.75	1.89	1.26	1.26	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	68.05	54.13	3.09	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	57.50	39.41	1.94	1.94	1.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	72.45	57.96	0.00	3.22	0.00	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	83.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	62.75	46.45	1.63	4.07	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	60.45	44.50	2.10	2.10	1.26	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	63.49	50.63	0.80	4.82	0.80	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	38.78	34.16	6.46	0.92	0.92	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	37.29	32.57	1.42	3.78	1.42	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	65.30	38.09	1.81	5.44	0.91	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	73.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	47.35	47.35	3.23	2.15	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	77.50	47.01	3.81	3.81	0.00	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	47.19	35.71	2.55	1.28	0.64	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	72.91	45.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	54.27	49.27	2.86	2.86	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	59.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	62.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	33.64	27.16	1.54	1.23	0.93	1.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	68.48	36.88	3.51	3.51	1.76	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	81.72	56.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	50.07	29.21	2.09	4.17	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	59.75	66.39	2.21	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	61.60	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.08	47.08	0.87	0.87	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	128.24	6.75	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	59.24	10.45	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	40.54	72.54	2.13	2.13	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	38.79	27.71	2.77	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	56.99	37.04	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	64.43	48.78	1.84	2.76	0.92	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	75.63	105.89	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	111.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	62.38	2.11	2.11	0.00	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.34	16.81	1.63	0.49	0.41	0.82	0.00
Keratinocyte - epidermal, donor2	11349-117G8	19.91	52.12	4.10	0.00	0.00	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	14.58	14.77	0.95	0.09	0.00	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	13.28	19.87	2.04	0.45	0.00	0.23	0.00
Keratocytes, donor1	11527-119I6	23.72	49.17	1.72	0.34	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	56.25	37.50	0.00	2.34	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	33.59	32.80	0.20	0.99	0.20	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	41.76	136.27	6.59	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	35.60	24.81	1.08	1.08	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	36.10	19.15	0.81	2.19	0.12	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	24.82	14.93	0.91	1.51	0.50	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	41.62	15.53	0.71	1.66	0.24	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	44.09	20.37	0.84	1.67	0.28	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.46	15.27	0.47	1.73	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	44.63	29.04	2.15	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	41.92	23.32	0.95	0.32	0.32	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	45.07	20.27	1.08	1.40	0.43	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	42.68	17.65	1.64	2.87	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	50.56	34.38	1.77	1.26	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	50.25	22.24	0.70	1.55	0.56	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.81	17.80	0.79	1.19	0.79	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	45.76	20.94	0.97	0.97	0.39	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	64.06	26.85	2.22	3.70	0.19	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	52.26	23.34	1.05	1.74	1.05	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	46.99	27.67	1.43	0.72	0.00	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	47.11	21.43	0.41	2.06	0.27	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	38.49	22.17	0.62	1.54	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	53.31	29.93	1.25	2.81	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	48.49	19.58	0.91	2.74	0.55	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	47.72	21.72	0.33	1.32	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	45.40	28.99	1.17	1.17	0.29	1.76	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	60.74	25.89	1.99	1.24	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	52.38	22.79	0.97	0.97	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	44.70	28.55	1.89	1.89	1.35	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.56	24.37	0.76	1.51	0.76	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	44.07	18.14	2.07	1.04	0.52	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	45.44	22.82	0.42	1.05	0.21	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	46.16	28.87	1.35	1.95	0.60	0.60	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.02	26.83	0.69	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	42.90	16.93	1.51	3.01	0.38	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	43.05	24.49	0.95	1.48	0.32	1.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	40.22	9.21	1.45	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	45.98	31.76	0.33	2.65	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	46.34	22.18	1.12	1.73	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	55.90	15.92	0.74	1.11	1.11	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.75	28.91	1.48	1.73	0.49	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.45	25.57	0.96	1.24	0.14	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.85	17.37	0.96	1.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.95	28.61	1.52	2.74	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.75	24.21	0.70	1.12	0.42	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	45.87	16.36	1.07	1.42	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	45.08	32.96	1.94	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	51.19	25.21	1.71	1.56	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	53.72	17.19	0.36	1.43	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	52.27	25.48	1.31	1.63	0.33	1.96	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	56.27	21.66	1.65	1.65	1.18	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	39.97	14.36	1.11	1.61	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.13	33.81	1.02	2.31	0.51	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	52.51	25.66	0.60	1.79	0.60	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	86.11	106.50	2.27	4.53	2.27	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	43.73	100.49	3.84	0.77	0.77	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	46.02	91.29	0.74	2.23	1.48	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	64.32	112.13	4.23	2.12	1.69	3.39	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	55.56	101.98	4.22	4.22	0.00	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	60.71	112.08	7.47	4.67	0.93	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	52.04	90.69	5.67	2.06	1.03	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	51.15	95.16	8.33	2.38	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	53.38	97.26	5.20	0.90	0.68	3.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	50.02	80.56	4.07	3.20	1.45	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	43.22	72.93	4.05	1.35	0.45	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	49.99	83.19	4.74	2.71	0.27	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	68.81	118.11	3.08	2.57	1.03	2.05	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	40.93	71.28	4.59	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.31	65.96	7.33	1.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.16	102.39	3.57	3.57	1.02	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.29	73.10	4.00	1.60	0.00	1.60	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	49.88	84.65	4.16	1.51	0.94	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	67.49	98.78	6.14	0.61	2.45	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	61.97	108.45	4.89	1.63	2.45	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.73	79.55	2.71	2.29	1.04	1.04	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	52.13	96.97	6.17	1.68	0.56	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	66.97	83.46	5.15	6.18	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	56.32	89.12	4.94	2.32	0.58	2.32	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	55.00	89.38	5.08	1.49	1.20	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	46.47	61.41	2.21	1.11	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	65.40	82.72	3.18	1.77	0.71	1.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	62.32	104.73	4.43	1.84	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	59.87	102.46	1.15	1.15	2.30	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	55.64	100.16	4.99	3.84	0.77	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	64.54	94.54	6.23	2.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.87	74.66	3.28	4.10	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	64.17	105.29	4.52	3.16	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	74.69	107.00	5.75	1.44	2.15	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.03	67.97	5.98	2.24	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	55.74	96.99	5.95	1.86	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	55.57	84.86	5.17	1.72	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	56.52	72.79	6.85	4.28	0.86	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.97	89.62	4.00	3.33	0.33	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	54.30	98.94	3.02	3.02	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	59.01	103.81	4.98	2.13	0.71	3.55	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	59.81	87.99	2.06	2.06	0.34	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	66.02	90.71	4.83	0.54	1.07	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	44.44	72.05	4.04	2.69	0.00	3.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	54.82	80.75	4.82	2.59	1.48	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	55.82	76.75	4.65	4.65	2.33	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	55.00	85.68	5.29	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	61.22	79.63	6.40	2.40	0.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	83.59	133.74	6.54	2.91	2.91	2.91	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	72.82	132.61	10.73	1.53	0.77	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	67.09	105.07	5.92	2.96	0.49	3.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	54.57	100.68	4.70	0.00	3.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	69.89	108.11	6.54	1.51	1.51	2.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	61.28	107.25	7.66	1.80	0.90	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	60.24	106.71	12.05	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	53.44	95.30	5.34	3.56	0.45	2.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	60.61	109.10	4.69	4.30	0.78	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	86.43	97.64	1.98	3.30	0.66	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	73.17	126.10	5.71	2.08	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	56.45	91.89	4.81	1.31	0.44	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	66.53	84.98	5.59	1.68	0.56	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	74.20	107.32	6.18	1.77	0.44	1.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	56.31	114.56	3.47	2.70	1.16	3.86	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	68.36	104.82	6.08	3.04	1.01	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	66.81	105.26	5.29	2.88	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.00	101.37	7.16	1.99	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	69.27	85.67	4.86	2.43	0.00	4.25	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	62.94	95.45	8.30	2.08	0.69	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	61.94	109.82	6.08	1.90	0.76	2.28	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	71.78	100.70	3.10	2.58	1.03	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.19	85.86	4.84	1.81	1.21	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	58.63	82.08	4.75	0.95	1.90	1.90	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	68.24	121.01	8.00	1.60	1.60	2.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	58.62	112.06	6.90	1.15	1.15	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	74.56	98.22	5.14	2.06	2.06	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	61.54	123.79	6.37	0.71	0.00	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.69	104.42	6.81	3.40	0.00	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	60.32	101.09	6.66	1.25	1.25	3.74	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	84.57	108.06	3.13	1.57	1.57	3.13	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	58.46	83.09	5.85	2.51	0.84	1.67	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	66.91	100.83	6.04	0.93	0.46	1.39	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	80.95	110.39	4.01	2.01	0.67	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	65.23	83.40	10.16	1.60	0.53	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	72.74	113.15	7.68	2.83	0.40	1.62	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	89.94	136.75	13.77	2.75	0.00	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	74.69	91.58	2.67	1.78	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	83.77	106.00	5.70	3.42	1.14	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	72.09	120.40	2.30	3.07	0.77	3.07	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	55.26	67.30	4.38	0.55	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	66.82	98.44	4.90	1.78	0.45	2.67	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	80.85	99.04	7.54	3.12	0.26	2.60	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	90.18	101.46	10.61	3.98	1.33	3.98	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	122.64	10.39	4.16	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	35.33	12.31	0.23	2.05	0.91	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	23.86	6.06	0.55	2.20	1.10	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	35.79	10.75	0.26	2.23	0.26	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	25.49	46.73	2.12	1.06	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	19.01	13.15	0.63	1.43	0.16	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	22.10	17.93	1.25	0.97	0.14	0.69	0.00
Mammary Epithelial Cell, donor1	11273-116H4	6.98	29.10	1.49	0.30	0.20	0.50	0.00
Mammary Epithelial Cell, donor2	11350-117G9	8.98	24.32	1.74	0.00	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	29.18	39.16	3.74	0.75	0.75	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	16.95	14.24	0.00	0.68	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	43.47	18.82	0.43	1.95	0.87	0.22	0.00
Mast cell, donor2	11565-120D8	66.57	25.56	4.46	5.65	2.97	0.59	0.30
Mast cell, donor3	11566-120D9	88.70	38.50	6.30	4.73	1.80	0.23	0.45
Mast cell, donor4	11567-120E1	64.89	22.52	4.25	2.66	1.60	0.35	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	45.69	20.74	0.33	1.33	0.67	0.33	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	50.78	33.27	4.09	2.33	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	83.75	22.26	0.46	4.02	0.80	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	97.58	33.31	2.01	4.85	1.84	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	48.95	7.36	0.20	0.99	0.20	0.70	0.00
Melanocyte - dark, donor2	11582-120F7	41.88	37.38	1.04	1.38	0.69	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	29.92	14.05	1.45	2.25	0.72	0.22	0.00
Melanocyte - light, donor1	11274-116H5	38.79	27.50	1.18	4.00	1.18	0.00	0.00
Melanocyte - light, donor2	11351-117H1	71.66	43.00	4.78	10.92	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	68.51	23.42	1.73	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.67	12.81	1.15	3.64	0.94	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	44.64	23.67	2.15	0.54	1.08	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	33.48	24.11	2.14	2.68	1.61	0.00	0.00
Meningeal Cells, donor1	11493-119E8	43.92	14.39	0.37	1.74	0.62	0.25	0.00
Meningeal Cells, donor2	11573-120E7	44.01	21.57	0.44	4.40	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	31.30	10.51	0.41	1.47	0.24	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.62	19.39	0.86	2.85	0.00	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	36.13	20.43	0.30	1.91	0.30	1.11	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	113.02	76.22	3.94	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	62.79	30.09	0.00	0.00	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	51.67	17.22	1.44	3.59	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.65	17.36	0.21	0.85	0.00	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	29.15	29.66	1.01	1.51	1.01	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	48.35	21.76	1.10	1.98	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	45.30	19.00	2.92	3.65	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	53.61	20.46	0.82	3.07	1.23	1.23	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.68	14.82	0.83	0.69	0.00	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	54.27	40.52	3.35	2.60	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.24	14.74	0.92	1.18	0.13	0.79	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	42.73	28.19	1.48	1.19	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	58.39	28.03	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	45.47	28.82	0.00	1.28	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.12	15.95	0.71	2.48	1.06	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.45	14.39	1.25	0.63	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	43.54	25.40	2.18	2.90	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	48.79	28.64	1.33	1.86	1.06	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	30.03	24.02	3.00	3.50	0.00	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	24.86	9.68	1.16	0.79	0.43	0.58	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	13.50	0.00	2.70	2.70	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	36.45	21.67	1.23	1.97	0.74	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	45.35	15.02	1.47	3.83	1.18	2.06	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	13.83	3.46	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.02	15.19	0.62	1.55	0.31	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	29.87	10.99	0.41	2.07	0.62	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	6.95	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.29	19.27	0.75	1.25	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	26.07	16.29	0.93	1.40	1.40	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	35.56	14.63	0.41	1.22	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.84	12.67	0.40	0.79	1.19	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	17.10	0.00	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	16.81	0.88	2.65	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	42.55	17.86	0.76	2.66	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	31.58	10.53	0.00	1.32	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.05	15.92	0.42	1.49	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	15.65	0.92	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.63	14.31	0.89	1.49	0.89	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	8.38	1.68	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.38	20.07	1.00	1.76	0.75	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	24.24	7.84	0.24	1.66	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	11.06	0.00	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.23	18.65	1.84	1.38	1.15	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.08	14.51	0.21	1.05	0.63	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.35	13.05	1.02	1.02	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.60	23.17	0.64	1.72	0.64	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	22.45	12.23	0.44	0.44	0.67	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.56	11.61	0.88	1.10	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	21.29	15.21	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	6.63	0.00	1.66	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.39	14.95	0.27	0.82	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	17.06	12.06	0.88	1.47	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	8.72	1.09	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	33.16	18.26	0.48	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.02	15.61	2.00	2.00	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	6.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.04	12.51	0.50	1.50	1.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	10.19	2.04	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.90	17.08	0.44	0.44	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	6.62	2.21	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	29.46	5.76	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	34.46	22.81	1.49	1.24	1.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	12.53	0.70	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	11.05	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	32.14	22.22	2.05	1.03	1.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.07	8.75	0.44	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.18	13.14	1.07	0.36	1.07	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	35.07	26.09	2.24	1.12	1.12	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	31.17	12.47	1.25	1.66	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	12.82	0.58	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	29.26	23.53	1.21	0.30	1.21	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	33.39	16.28	1.67	0.83	1.67	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	36.09	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	24.94	6.46	2.77	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.89	12.52	0.57	1.14	1.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.71	15.06	1.11	0.83	0.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	36.54	27.73	2.33	2.85	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	28.31	17.16	1.29	0.43	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	32.39	17.15	1.91	1.91	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	27.49	26.96	1.07	0.00	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	55.68	31.13	2.39	2.39	0.90	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.41	13.28	1.41	0.71	0.42	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	47.46	31.21	3.82	2.55	0.96	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.50	21.45	1.77	0.66	1.99	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.27	14.79	1.90	0.76	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	34.09	30.40	2.56	0.85	2.56	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	44.49	31.46	3.69	0.98	2.46	0.98	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	41.06	12.38	0.65	0.00	0.65	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.11	27.34	2.65	2.35	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	54.78	26.53	1.44	3.17	1.73	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.09	20.20	0.82	0.82	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.86	20.55	0.30	2.68	1.19	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	56.50	7.53	0.00	3.77	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	62.38	23.17	1.78	5.35	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	42.71	14.79	0.66	0.33	2.96	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	69.43	21.04	4.21	1.05	3.16	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	47.25	18.98	1.78	2.37	0.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	31.66	15.83	1.86	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	40.93	14.65	1.13	2.63	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.21	13.32	0.53	2.66	0.80	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	43.20	15.95	0.79	2.71	0.90	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	16.94	2.21	2.95	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	45.07	13.92	1.83	2.20	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	21.78	1.56	4.67	4.67	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.79	14.96	1.07	1.60	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	27.05	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	50.50	21.21	1.01	3.03	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	27.83	13.49	1.26	1.26	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	10.90	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	5.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	4.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	3.02	1.51	0.00	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	17.13	11.42	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	29.36	16.31	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	23.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	37.65	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.22	8.40	1.29	1.08	0.22	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	29.27	14.63	0.52	0.00	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	46.06	22.03	0.00	3.34	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	50.92	28.80	0.42	2.09	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.73	24.72	0.57	2.28	0.95	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	44.68	1.60	6.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	43.52	21.08	2.04	2.04	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	56.92	46.46	2.51	1.26	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	70.20	44.40	1.39	3.72	0.23	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	56.21	30.27	2.43	1.89	1.35	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	34.69	22.07	0.63	1.68	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	22.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	71.48	30.77	1.99	2.48	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.53	32.75	0.81	1.08	0.27	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	61.88	31.06	1.59	2.72	1.36	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	58.95	30.54	1.31	2.94	0.49	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	38.64	27.34	0.91	1.28	0.18	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	55.17	26.52	1.06	1.06	0.00	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	45.62	28.21	2.40	3.60	1.80	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	17.72	0.66	0.66	0.66	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	58.71	31.71	1.14	3.09	1.14	0.65	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	31.22	21.52	0.71	1.59	0.88	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	54.15	28.83	0.70	2.81	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	52.41	37.24	2.30	1.38	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	60.41	34.71	2.57	2.57	0.64	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	34.83	12.07	0.69	0.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	10.11	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.74	25.17	0.89	1.34	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	53.35	33.45	1.69	1.27	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.99	34.42	0.47	1.42	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	63.96	33.91	3.00	2.58	2.58	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	53.32	20.33	1.00	2.00	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	44.64	22.99	1.35	1.80	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	50.39	19.05	1.19	1.98	1.19	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	54.79	26.00	0.93	2.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.05	40.49	1.51	1.14	0.76	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	57.68	20.53	1.63	2.28	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.40	18.30	0.44	1.74	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.49	14.47	1.36	0.90	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	57.32	28.22	0.00	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.87	29.92	4.65	2.66	1.99	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.57	28.27	0.00	4.96	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	45.56	21.06	1.53	2.68	1.53	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	60.49	22.68	0.60	1.81	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	33.37	17.46	0.44	2.21	0.88	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.08	16.26	0.68	3.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	15.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	65.85	39.02	3.05	4.27	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	46.58	23.29	0.63	2.52	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	69.00	20.88	1.51	3.03	0.91	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.93	20.57	0.00	2.37	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	11.34	0.00	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	25.96	15.78	0.99	1.99	0.75	0.75	0.00
Myoblast, donor2	11322-117D8	43.92	20.33	0.38	2.69	0.77	0.38	0.00
Myoblast, donor3	11398-118D3	32.79	17.83	0.50	1.85	0.50	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	35.17	39.55	0.73	0.58	1.75	0.73	0.00
Natural Killer Cells, donor1	11230-116C6	46.44	56.89	13.84	0.62	2.77	2.77	22.14
Natural Killer Cells, donor2	11311-117C6	62.42	66.64	13.57	0.60	5.73	4.22	37.39
Natural Killer Cells, donor3	11387-118C1	62.39	58.71	13.80	0.74	2.58	2.94	24.30
Neural stem cells, donor1	11275-116H6	34.48	49.00	3.63	0.73	0.00	1.09	0.00
Neural stem cells, donor2	11352-117H2	46.22	44.29	5.78	1.93	0.00	5.78	0.00
Neurons, donor1	11494-119E9	91.03	47.79	4.55	6.83	1.14	2.28	0.00
Neurons, donor2	11574-120E8	50.20	36.33	1.76	4.18	0.22	0.44	0.00
Neurons, donor3	11655-122E8	73.99	40.29	4.93	9.87	0.82	0.82	0.00
Neutrophils, donor1	11233-116C9	34.34	11.14	3.71	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	26.09	5.80	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	25.04	12.22	3.67	1.22	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	19.24	21.25	0.71	0.83	0.24	0.47	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	44.93	42.00	1.95	1.63	0.65	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	42.92	25.87	1.80	1.60	1.00	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	29.46	20.79	1.38	0.83	0.55	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	33.44	32.71	2.32	1.16	0.72	1.01	0.00
Olfactory epithelial cells, donor3	11935-125I9	27.01	23.04	0.45	0.68	0.57	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	26.30	13.34	0.49	1.27	0.39	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	25.88	23.47	1.20	1.20	0.60	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	38.28	18.50	1.49	2.34	0.85	1.06	0.00
Osteoblast - differentiated, donor2	11353-117H3	65.16	52.58	4.57	4.57	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	59.59	49.04	2.48	1.86	0.62	1.24	0.00
Osteoblast, donor1	11277-116H8	78.76	67.23	2.54	4.50	0.20	1.56	0.00
Osteoblast, donor2	11354-117H4	19.66	7.73	0.00	2.11	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	51.54	30.75	0.71	3.73	0.71	1.07	0.00
Pancreatic stromal cells, donor1	11249-116E7	25.94	11.37	0.25	0.84	0.34	0.34	0.00
Pericytes, donor1	11491-119E6	51.07	30.93	1.56	2.45	0.33	0.22	0.00
Pericytes, donor2	11571-120E5	53.65	33.95	2.04	2.72	1.13	0.45	0.00
Pericytes, donor3	11652-122E5	41.50	21.77	1.63	2.44	0.20	0.61	0.00
Perineurial Cells, donor1	11499-119F5	19.89	9.15	0.34	0.79	0.11	0.00	0.00
Perineurial Cells, donor2	11579-120F4	30.82	21.16	1.10	1.29	0.46	0.55	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.20	43.67	3.19	0.32	1.27	0.32	3.51
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	42.12	47.75	7.59	1.47	1.71	0.73	3.67
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.31	35.20	8.67	0.78	1.29	1.16	7.12
Placental Epithelial Cells, donor1	11278-116H9	87.77	146.13	14.11	2.15	2.87	3.11	0.00
Placental Epithelial Cells, donor2	11355-117H5	64.32	47.68	3.33	2.22	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	39.07	38.68	3.34	1.18	1.77	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	46.52	31.65	2.53	3.16	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	33.77	25.89	1.50	1.88	0.56	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	20.49	12.53	0.39	1.17	0.26	0.52	0.00
Preadipocyte - breast, donor2	11328-117E5	32.20	25.22	2.03	1.13	0.45	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	32.18	24.30	1.70	2.02	0.32	0.75	0.00
Preadipocyte - omental, donor2	11329-117E6	32.74	28.37	0.00	1.75	0.87	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	23.78	15.61	0.86	0.86	0.14	0.72	0.00
Preadipocyte - perirenal, donor1	11469-119C2	44.29	19.69	1.97	0.00	2.95	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	75.55	43.00	4.91	0.61	1.23	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	33.47	17.53	0.53	1.42	0.18	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	48.53	20.77	1.19	2.55	1.02	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	30.09	14.81	0.37	1.49	0.47	0.37	0.00
Preadipocyte - visceral, donor2	11357-117H7	32.67	16.57	0.92	1.84	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	40.33	18.18	0.52	1.57	0.73	0.42	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	54.91	63.81	5.58	2.11	1.06	1.81	0.00
Prostate Epithelial Cells, donor2	11331-117E8	16.52	19.50	0.95	0.68	1.08	1.08	0.00
Prostate Epithelial Cells, donor3	11404-118D9	7.90	20.39	1.59	0.24	0.12	0.80	0.00
Prostate Stromal Cells, donor1	11254-116F3	29.04	19.36	0.46	1.03	0.11	0.91	0.00
Prostate Stromal Cells, donor2	11332-117E9	32.81	13.99	0.54	1.43	0.18	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	43.90	21.69	1.04	2.50	0.42	1.04	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.12	36.13	2.19	1.09	0.36	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	20.31	19.82	0.62	1.11	0.28	0.49	0.00
Renal Epithelial Cells, donor1	11517-119H5	35.51	54.78	3.55	1.52	0.51	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	41.26	48.37	2.13	0.71	1.42	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.13	16.83	0.95	1.16	0.21	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	61.96	14.98	0.00	1.36	1.36	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	64.42	17.79	1.48	1.75	1.21	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	37.30	29.31	1.55	1.11	0.67	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	86.51	31.94	1.33	5.32	3.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	31.47	38.96	1.76	1.10	0.44	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	39.50	54.55	2.51	1.25	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	37.73	48.55	3.05	2.50	0.83	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.21	28.18	2.68	1.61	0.54	1.61	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	31.21	44.70	2.53	0.42	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	37.41	37.61	1.16	1.54	0.58	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	44.34	27.74	1.56	1.81	0.26	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	48.04	28.71	1.71	1.71	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	61.75	39.11	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.61	38.39	1.25	1.25	0.25	1.51	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.59	32.74	1.60	1.07	0.80	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	8.04	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	2.75	0.55	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	5.80	0.00	0.58	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	9.49	6.11	0.13	0.13	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	16.68	8.54	0.20	0.50	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.29	5.13	0.22	1.23	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.31	4.34	0.00	0.62	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.95	7.69	0.00	0.47	0.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.66	9.94	0.23	1.16	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.09	6.16	0.14	0.68	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	14.82	7.56	0.15	0.30	0.15	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.79	8.24	0.18	1.08	0.36	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.20	6.31	0.29	0.72	0.29	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.99	8.05	0.75	0.86	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.01	6.86	0.00	0.66	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.72	5.54	0.76	0.76	0.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	16.40	7.17	0.19	1.12	0.19	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	12.40	4.13	0.00	0.56	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.08	5.18	0.66	0.66	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.39	5.26	0.10	0.78	0.19	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.23	10.31	0.19	0.76	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.28	5.34	0.11	1.17	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.86	5.89	0.28	0.56	0.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.63	7.01	0.17	0.68	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.67	4.92	0.36	1.09	0.00	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.47	7.48	0.00	0.61	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.28	9.13	0.00	1.07	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.93	8.26	0.00	1.42	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.67	7.74	0.20	1.39	0.79	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	25.96	9.35	0.47	0.94	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.63	5.18	0.00	0.62	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.01	10.84	0.44	1.33	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.93	10.24	1.04	0.63	0.42	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	14.54	5.79	0.54	0.54	0.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.41	8.34	0.17	0.51	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.46	8.29	0.39	0.77	0.39	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.55	6.36	0.17	0.17	0.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.89	9.05	0.14	0.41	0.00	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	15.92	9.85	0.00	0.66	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	14.83	4.60	0.00	0.68	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.24	11.54	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.39	7.73	0.00	0.53	0.27	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.38	6.78	0.55	0.97	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.19	8.57	0.48	0.24	0.24	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.76	9.07	0.40	0.60	0.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.81	6.31	0.38	0.47	0.09	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.01	10.13	0.00	1.05	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.23	10.58	0.00	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.58	8.20	0.12	0.37	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	11.06	7.57	0.00	0.44	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.86	12.78	0.00	1.83	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.58	9.95	0.60	0.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.43	13.12	1.36	0.90	0.45	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.88	11.68	0.00	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	11.34	13.22	0.47	0.24	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.92	13.45	0.21	0.64	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	19.83	7.81	0.60	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	69.96	30.66	1.50	3.01	0.94	0.19	0.00
Schwann Cells, donor2	11578-120F3	37.43	20.41	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	47.54	29.58	1.10	2.19	0.22	0.88	0.00
Sebocyte, donor1	11220-116B5	15.34	9.86	1.10	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	15.17	21.14	0.00	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	20.82	23.50	2.06	0.21	0.62	1.03	0.00
Sertoli Cells, donor1	11255-116F4	31.48	23.19	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	36.72	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	28.50	29.12	1.23	1.50	0.35	0.79	0.00
Skeletal Muscle Cells, donor2	11358-117H8	86.02	39.76	3.61	1.45	0.72	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	103.67	30.93	0.00	3.34	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	47.76	22.15	1.10	2.04	0.47	0.31	0.00
Skeletal Muscle Cells, donor5	11455-119A6	43.40	19.77	0.30	1.64	0.59	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	48.79	16.01	0.31	2.77	0.46	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.71	20.54	0.63	1.76	0.25	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.54	25.11	1.43	1.14	0.00	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	39.09	20.14	1.29	2.08	0.40	0.20	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	30.08	12.81	0.59	2.61	0.17	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	57.18	66.59	0.72	2.90	1.45	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	75.13	42.52	1.51	3.03	0.96	0.55	0.00
Skin - palm, donor1	10286-104F7	29.55	42.98	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	29.12	44.98	3.32	1.30	1.15	1.59	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.09	30.26	4.09	0.82	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.08	45.44	3.38	1.04	0.26	1.17	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.20	27.11	1.81	0.70	0.14	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	9.14	28.41	2.11	0.28	0.14	1.13	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	7.40	20.51	2.54	0.63	0.00	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	7.94	28.11	1.80	0.22	0.15	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	21.29	19.44	2.47	1.54	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.00	6.23	0.44	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.15	36.45	3.53	4.11	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.95	24.75	0.66	1.55	0.22	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	53.95	49.22	2.76	1.97	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	34.77	58.72	1.55	1.55	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	38.03	2.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	41.52	34.20	1.46	1.60	0.40	1.20	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.13	15.29	1.11	1.55	0.44	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.55	34.18	3.71	2.43	1.28	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	36.79	21.49	0.33	0.65	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.67	15.36	1.18	2.36	0.30	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.60	12.67	0.57	1.28	0.57	0.85	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	50.10	17.24	0.81	3.74	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.40	24.66	0.91	1.83	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	61.63	39.15	1.77	2.02	0.51	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	30.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	66.28	37.67	1.43	3.81	1.91	2.86	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.35	22.27	0.59	1.03	0.29	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	33.15	26.26	0.43	1.72	0.43	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	35.58	27.71	0.63	1.05	0.42	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	52.28	40.84	3.09	1.55	0.62	1.39	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	50.66	91.62	6.47	0.00	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	50.81	25.10	0.90	1.49	1.79	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	47.45	22.19	2.73	2.73	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.05	18.06	0.79	0.63	0.16	0.24	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.43	22.04	1.71	1.21	0.00	0.70	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.76	31.63	3.87	0.46	1.82	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	57.36	41.06	6.04	4.23	1.21	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	31.00	15.37	1.32	1.06	0.53	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	28.63	13.58	0.53	1.07	0.13	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	35.56	32.31	0.75	0.63	0.75	1.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.02	16.49	0.51	0.76	0.76	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	40.71	21.11	1.06	1.81	0.30	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	61.51	30.01	0.75	2.25	0.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	51.69	12.92	0.00	3.88	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	46.51	35.35	2.33	1.86	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	33.32	27.26	2.52	0.50	1.51	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.67	37.92	1.88	0.63	0.63	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.56	22.12	0.59	0.88	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.32	14.25	0.58	2.25	0.50	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.70	19.62	1.87	0.47	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	40.58	26.62	1.15	2.01	0.14	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	60.42	32.12	1.27	3.06	0.25	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	57.91	39.68	1.69	3.01	1.13	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	18.17	13.83	1.12	0.98	0.14	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	17.60	11.90	0.25	0.75	0.34	0.50	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	32.38	29.52	0.95	1.43	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	33.27	22.26	1.47	1.96	0.49	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.28	11.93	1.33	1.10	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.97	23.99	1.17	1.76	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.54	21.77	1.17	0.78	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	31.73	21.69	0.26	1.85	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.52	9.67	0.37	0.37	1.12	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	29.47	21.56	1.08	1.44	0.72	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	44.57	35.49	2.56	1.99	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	29.93	18.51	0.39	1.18	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	36.57	10.67	0.76	0.76	0.25	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	33.14	26.36	2.80	0.80	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	44.73	20.06	0.84	2.09	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	49.50	27.96	0.92	0.46	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	24.41	17.34	1.01	0.34	0.50	1.01	0.00
Synoviocyte, donor2	11368-117I9	34.87	19.28	1.51	0.67	0.50	0.50	0.00
Synoviocyte, donor3	11440-118H9	34.85	17.87	0.89	0.45	0.45	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	35.73	28.23	2.14	1.07	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	33.69	33.69	1.98	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	52.10	33.57	1.39	1.16	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	11.76	23.23	1.94	0.65	0.43	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	32.47	40.20	1.55	2.32	0.77	1.16	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	23.48	47.53	4.01	0.57	2.29	2.29	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.05	31.49	1.23	0.98	0.49	0.37	0.00
Urethra, donor2	10319-105A4	30.57	19.78	3.60	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	24.97	14.08	1.59	0.53	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	21.23	14.42	0.40	0.80	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	26.59	13.06	1.38	0.23	0.69	1.15	0.00
Urothelial cells, donor0	11216-116B1	11.59	10.03	0.67	1.11	0.22	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.05	32.03	0.00	0.89	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	58.61	25.73	0.00	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	21.90	0.00	0.68	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	30.99	23.76	1.03	0.69	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	39.51	27.89	0.58	1.16	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	18.74	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	40.38	22.03	2.75	3.67	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	23.74	1.83	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	12.09	34.79	2.47	0.37	0.49	0.62	0.00
Wilms' tumor cell line:HFWT	10597-108E3	17.60	31.68	1.76	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	13.41	19.83	0.28	0.56	0.56	0.28	0.00
achilles tendon, donor2	10292-104G4	35.13	24.80	4.13	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.67	18.10	0.51	0.25	0.51	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.61	21.59	1.39	2.55	0.23	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	17.57	32.76	1.19	0.71	0.59	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	33.74	16.05	0.82	1.36	0.54	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	47.78	23.89	0.56	0.84	0.28	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.24	43.35	0.63	5.08	0.85	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	50.09	27.77	0.00	2.18	1.91	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	61.69	27.76	0.44	3.08	1.32	1.76	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	51.86	24.09	0.00	2.86	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	87.37	31.84	0.39	5.05	2.33	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	20.79	11.96	0.37	2.02	0.18	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	39.01	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.40	15.10	0.70	1.39	0.93	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	67.06	17.86	0.26	4.66	0.26	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	55.82	17.83	0.29	1.75	0.58	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	37.18	19.98	0.46	1.86	0.93	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.02	17.27	0.82	1.23	1.65	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	56.79	31.92	1.23	4.30	0.31	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.72	18.78	0.43	1.28	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	33.06	12.44	0.91	0.61	0.30	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	36.11	16.37	0.24	3.37	0.72	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.77	18.49	0.45	2.45	0.67	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.03	11.01	0.33	2.00	2.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	14.87	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	63.66	25.99	2.26	2.64	0.75	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	42.30	12.65	1.31	1.74	1.31	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	18.74	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	24.02	37.92	3.77	0.24	1.65	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	22.65	15.82	0.16	0.78	0.31	0.31	0.00
adipose, donor1	10184-103D4	92.07	27.56	1.17	2.93	0.00	1.17	0.00
adipose, donor2	10185-103D5	64.07	111.11	5.27	6.49	0.41	0.81	0.00
adipose, donor3	10186-103D6	60.72	73.79	3.81	3.00	0.54	1.63	0.00
adipose, donor4	10187-103D7	63.27	32.94	0.87	2.60	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.55	29.35	1.58	2.05	0.32	0.95	0.00
adrenal gland, adult, pool1	10081-102A9	43.65	25.46	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.01	15.07	0.13	0.40	1.33	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.44	33.94	0.36	1.79	2.14	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	18.08	15.30	2.78	0.70	2.32	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	36.18	29.75	0.68	0.68	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	12.67	15.61	1.77	0.59	1.47	0.00	0.00
amygdala - adult, donor10196	10167-103B5	21.34	21.34	3.56	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	31.43	14.19	0.81	0.20	0.61	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	40.67	38.09	1.94	2.90	0.32	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	32.72	76.40	1.91	1.02	0.51	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	36.40	15.88	1.32	0.44	2.65	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	16.70	32.07	2.00	1.00	2.00	0.67	0.00
aorta, adult, pool1	10052-101G7	27.07	21.38	1.18	1.37	0.00	0.20	0.20
appendix, adult	10189-103D9	23.29	36.48	2.33	0.39	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	83.23	47.81	2.75	3.78	3.78	2.06	0.00
artery, adult	10190-103E1	29.89	32.61	1.36	1.36	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	29.84	29.70	2.46	0.29	0.14	0.43	0.00
b cell line:RPMI1788	10427-106D4	8.48	20.22	0.59	0.30	0.30	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	26.63	16.09	0.83	1.66	0.00	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.14	23.42	1.29	0.40	1.59	0.40	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	24.10	49.88	1.51	0.17	0.50	1.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	44.74	31.32	0.56	2.24	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	20.32	15.64	0.54	0.98	0.11	0.00	0.00
blood, adult, pool1	10053-101G8	28.79	37.65	8.86	0.00	2.21	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	23.98	0.86	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	41.84	20.24	0.67	2.70	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	31.78	27.68	4.10	3.08	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	19.15	33.74	1.34	1.00	0.33	0.56	0.00
brain, fetal, pool1	10085-102B4	98.84	37.40	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	45.59	33.70	0.99	0.99	0.33	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	32.08	72.77	3.37	0.37	0.50	1.87	0.00
breast, adult, donor1	10080-102A8	31.57	11.36	1.26	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.66	21.72	0.25	1.40	0.25	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	24.74	49.17	3.71	1.24	0.62	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	41.90	23.71	0.46	1.84	0.23	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.01	41.64	2.18	0.24	0.48	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	39.96	15.99	1.88	1.88	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	18.27	43.97	0.98	0.77	1.09	1.20	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	35.49	10.77	0.32	1.58	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	29.01	28.21	0.53	1.60	1.06	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	19.57	34.54	1.15	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	26.77	29.28	1.34	0.33	0.67	0.84	0.00
caudate nucleus, adult, donor10258	10379-105H1	25.98	41.26	2.29	0.76	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	39.55	33.69	0.00	1.46	0.00	1.83	0.37
cerebellum - adult, donor10196	10173-103C2	14.57	8.74	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	23.49	17.08	0.43	0.43	0.43	0.00	0.00
cerebellum, adult, pool1	10083-102B2	25.87	40.36	0.69	0.34	0.00	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	39.85	29.89	0.00	0.83	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	31.27	45.89	3.03	2.27	0.76	1.01	0.00
cerebrospinal fluid, donor2	10294-104G6	25.58	35.08	3.65	0.00	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.52	35.37	2.44	0.58	0.58	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	15.91	41.93	1.82	0.17	0.99	0.33	0.00
cervix, adult, pool1	10013-101C4	32.65	26.67	0.63	0.94	0.10	0.31	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	79.14	54.48	2.93	2.37	0.70	2.23	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	24.82	1.31	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.51	29.33	0.99	0.75	0.25	1.24	0.00
choriocarcinoma cell line:SCH	10785-110H2	26.00	19.10	1.23	0.74	0.37	1.23	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	19.69	31.31	1.90	0.95	0.24	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	10.26	20.23	2.28	0.28	0.85	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	40.27	26.55	1.39	1.69	0.40	0.89	0.00
chorionic membrane cells, donor3	12240-129G8	9.89	15.94	0.55	0.00	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	30.29	44.43	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.02	12.68	0.96	2.50	0.77	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	28.09	10.35	0.42	1.06	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	24.14	12.33	1.28	1.03	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	25.16	13.55	0.48	1.69	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.56	10.18	0.41	0.20	0.20	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	40.63	7.66	0.59	1.77	0.29	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	22.15	9.12	1.04	0.78	0.00	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	41.83	24.00	1.14	0.91	0.69	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	24.64	19.95	0.87	1.21	0.17	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	52.53	35.69	2.01	2.93	0.55	1.46	0.00
colon carcinoma cell line:COLO-320	10420-106C6	23.18	33.45	0.38	1.14	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	46.41	21.42	0.00	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	34.31	54.76	3.41	0.82	0.35	0.24	0.12
colon, fetal, donor1	10070-101I7	22.25	26.57	1.24	0.62	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	64.17	50.42	9.17	4.58	0.00	0.00	36.67
common myeloid progenitor CMP, donor2	12134-128E1	150.22	100.15	0.00	25.04	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.92	37.82	1.27	0.00	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	17.06	32.30	1.66	0.60	0.30	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	14.95	34.55	1.27	0.14	0.14	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	23.88	21.89	0.88	0.88	0.11	0.66	0.00
cruciate ligament, donor2	10295-104G7	24.31	22.69	1.62	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	22.47	0.00	0.80	1.61	0.00	0.00
diencephalon, adult	10193-103E4	28.32	37.92	1.92	0.96	0.24	1.68	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.81	29.39	1.84	1.38	0.69	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.59	34.11	1.54	0.51	0.26	1.54	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	17.81	38.03	0.72	0.48	1.93	2.41	0.00
ductus deferens, adult	10196-103E7	19.44	42.36	2.49	1.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	30.24	0.00	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	33.84	25.75	2.21	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	24.94	22.71	1.16	1.07	0.33	0.58	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	43.08	216.74	13.55	0.89	7.77	6.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	62.48	82.82	1.86	2.15	0.43	4.44	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	24.05	25.28	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	12.11	17.86	0.91	0.00	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.30	28.71	1.85	1.54	1.85	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	17.08	40.72	1.31	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.80	46.59	1.01	0.34	0.00	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	18.85	44.04	2.72	0.72	0.91	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	46.96	39.24	1.61	1.77	1.93	1.29	0.00
epidermoid carcinoma cell line:A431	10426-106D3	6.78	15.01	1.45	0.11	0.22	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.76	19.47	1.21	0.55	0.66	0.77	0.00
epididymis, adult	10197-103E8	32.02	57.14	3.77	1.26	0.21	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.92	34.42	1.06	0.18	0.18	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.34	16.12	1.18	0.00	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.91	25.69	0.26	1.05	1.97	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	12.01	23.33	0.39	0.30	0.59	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	27.78	31.82	1.34	1.12	1.12	1.01	0.00
esophagus, adult, pool1	10015-101C6	25.48	24.63	0.53	1.49	0.21	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.96	17.03	0.25	0.25	0.13	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	21.73	24.15	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	14.73	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	16.37	4.46	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	20.64	2.29	1.15	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	33.52	24.78	11.66	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	34.58	26.95	1.27	1.27	0.76	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	34.11	31.67	1.41	1.15	0.64	0.51	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	46.06	32.76	0.71	2.37	0.47	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	24.11	18.11	1.13	1.31	0.28	0.66	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	23.42	18.62	0.30	0.60	0.90	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	8.78	13.35	0.55	0.18	0.09	0.18	0.00
gall bladder, adult	10198-103E9	39.84	30.66	0.97	0.97	0.72	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	84.29	67.11	1.61	2.68	1.07	0.54	2.15
gamma delta positive T cells, donor2	11938-126A3	49.30	73.20	6.35	0.37	2.24	1.12	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	16.47	23.23	0.21	0.63	0.21	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.00	56.48	2.32	0.58	1.55	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	39.68	43.12	5.41	0.98	0.00	0.82	0.00
gastric cancer cell line:GSS	10560-108A2	75.96	63.15	1.83	1.83	0.00	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.26	51.17	1.60	0.91	0.91	1.37	0.00
giant cell carcinoma cell line:LU65	10487-107B1	19.62	10.90	0.46	0.57	0.46	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	16.24	31.63	0.70	0.14	0.14	0.98	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	6.98	30.68	1.50	0.00	0.75	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.53	33.88	0.84	0.53	0.11	0.74	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.21	31.32	1.26	1.12	0.28	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	30.68	34.44	0.33	0.77	0.22	0.11	0.00
glioma cell line:GI-1	10413-106B8	16.11	11.13	0.59	0.59	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	16.76	32.80	0.73	0.73	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	19.28	22.70	1.46	0.98	0.49	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	38.34	62.98	4.11	2.74	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	31.44	39.44	1.07	0.53	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	97.89	66.07	2.45	0.00	0.00	4.89	7.34
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	54.64	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	177.70	151.57	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.60	13.12	1.60	0.96	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	64.28	23.41	1.84	2.75	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	54.87	20.12	0.91	5.03	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	70.85	37.36	1.93	3.86	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	61.80	30.18	5.75	5.75	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	72.02	30.18	4.12	6.17	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	49.66	2.21	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	20.69	30.46	2.01	0.86	2.01	0.29	1.15
heart - mitral valve, adult	10205-103F7	20.33	12.86	0.90	1.49	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	16.47	17.26	0.26	1.05	0.78	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	35.80	9.16	0.00	3.33	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	37.95	19.59	1.22	2.45	0.82	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	40.45	36.20	1.28	1.70	0.85	0.43	0.00
heart, adult, pool1	10016-101C7	36.11	14.26	0.69	0.69	0.92	0.23	0.00
heart, fetal, pool1	10046-101G1	25.98	18.79	0.62	1.03	0.21	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.52	9.87	0.62	1.23	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	27.35	26.16	0.00	0.00	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.05	95.03	4.53	2.76	1.44	1.77	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	50.86	110.57	6.43	1.46	1.46	1.21	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	48.30	97.21	5.36	0.91	1.52	1.31	0.00
hepatoma cell line:Li-7	10484-107A7	32.47	26.47	1.45	0.56	0.67	0.78	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	11.36	28.54	1.41	0.40	0.10	0.60	0.00
hippocampus - adult, donor10196	10169-103B7	12.30	26.50	3.79	1.89	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	30.61	19.19	1.02	1.63	1.43	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	29.38	41.33	3.98	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	49.35	29.26	2.11	2.47	1.41	3.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	103.15	18.31	1.22	4.88	3.05	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	103.28	15.12	1.37	4.32	1.77	1.96	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	104.10	15.74	0.76	3.81	0.51	1.02	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	99.80	49.62	2.82	5.07	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	91.41	33.05	3.10	4.13	0.52	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	107.05	49.73	1.52	7.97	0.76	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	66.86	60.43	3.21	2.04	1.17	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	56.87	61.18	3.23	4.09	0.22	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	62.98	66.73	0.42	3.34	0.83	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	62.28	67.96	3.32	2.60	0.47	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	63.00	57.38	3.05	3.05	0.00	0.64	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	67.33	63.96	4.71	2.02	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	100.62	12.52	1.72	3.91	0.94	1.25	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	96.29	13.26	2.95	5.40	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	114.33	16.58	0.87	2.62	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	100.42	46.01	2.48	5.54	0.19	0.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	95.94	47.10	1.74	3.92	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	132.94	58.97	2.50	5.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	59.72	86.09	5.27	4.14	0.19	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.84	78.67	5.00	4.09	0.45	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	67.35	105.87	4.70	4.07	0.31	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	67.12	71.04	4.90	2.29	0.33	0.98	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	63.58	73.74	6.39	3.19	0.58	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	79.21	119.27	5.98	5.08	2.09	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	88.68	21.25	1.66	5.17	0.92	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	86.16	19.97	1.43	4.56	3.14	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	126.17	24.50	2.04	5.72	1.22	3.67	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	96.12	46.83	0.70	4.22	1.41	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	88.37	52.26	2.53	4.43	0.95	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	127.10	56.89	1.82	4.84	0.30	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	60.50	73.43	2.59	2.59	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	57.78	89.00	1.33	2.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	55.15	63.62	2.82	3.08	0.26	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	60.33	62.38	1.53	2.05	1.02	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	74.97	95.41	3.79	3.79	2.27	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	70.57	87.04	3.70	5.04	0.00	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	99.02	24.15	2.17	3.62	1.21	1.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	120.33	27.19	0.89	4.01	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	121.46	27.32	2.44	6.83	0.98	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	95.96	51.04	1.83	3.67	0.00	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	42.29	29.28	0.00	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	104.91	44.35	1.32	5.63	0.33	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	55.28	83.19	2.74	6.57	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	70.57	78.53	2.17	5.43	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	59.43	72.24	2.14	3.56	1.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	69.22	78.76	0.00	3.58	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	53.09	63.79	3.25	2.71	0.41	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	57.92	72.47	2.69	3.77	0.27	0.54	0.00
immature langerhans cells, donor1	11904-125F5	16.71	37.05	3.39	0.00	1.94	0.48	0.73
immature langerhans cells, donor2	11905-125F6	16.63	52.28	4.75	0.00	1.58	0.79	0.79
insula, adult, pool1	10039-101F3	32.36	21.77	1.14	1.23	0.47	0.95	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	25.04	81.61	5.20	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	22.13	45.16	2.00	1.00	0.40	0.40	0.00
kidney, fetal, pool1	10045-101F9	30.49	33.53	1.91	1.13	0.14	0.64	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	23.72	20.02	1.85	0.71	0.99	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	30.14	46.59	3.87	0.83	2.35	0.97	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.09	31.56	1.10	0.55	1.10	0.37	0.00
left atrium, adult, donor1	10079-102A7	29.97	14.17	1.63	0.00	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	30.34	16.69	0.51	0.00	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	38.58	22.71	1.64	1.37	0.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	39.88	39.52	3.23	2.16	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	38.59	25.54	0.54	1.09	0.00	1.63	0.00
leiomyoma cell line:15425	10571-108B4	27.44	24.52	0.49	1.46	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	25.40	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	37.64	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.10	28.33	1.42	1.06	0.83	0.71	0.00
liposarcoma cell line:KMLS-1	10782-110G8	26.56	29.84	2.66	0.78	0.16	0.47	0.00
liposarcoma cell line:SW 872	10726-110A6	30.46	52.03	1.34	1.58	0.97	0.61	0.00
liver, adult, pool1	10018-101C9	35.82	44.08	1.78	0.97	0.65	0.16	0.00
liver, fetal, pool1	10086-102B5	45.15	33.87	0.00	1.88	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	15.17	32.66	1.75	0.58	0.15	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	23.99	24.36	0.92	0.18	0.37	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	32.45	89.72	5.92	1.13	0.85	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	28.60	24.40	0.42	0.84	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	14.25	27.13	0.83	0.55	0.28	0.83	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	20.68	36.54	1.38	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	22.28	32.43	1.19	0.92	0.92	0.79	0.00
lung, adult, pool1	10019-101D1	29.53	18.43	0.83	0.71	0.00	0.35	0.00
lung, fetal, donor1	10068-101I5	26.83	17.41	0.29	0.29	0.00	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	32.53	16.50	0.46	0.92	0.46	0.00	0.00
lymph node, adult, donor1	10077-102A5	32.66	21.77	0.47	0.47	0.47	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	27.40	15.78	0.88	0.44	1.75	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.87	63.09	2.11	0.45	0.45	0.60	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	25.48	22.94	0.85	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	23.09	57.72	3.11	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	33.20	44.41	1.87	0.62	0.42	0.21	0.00
mature adipocyte, donor3	12233-129G1	20.86	50.49	1.19	0.71	0.47	0.24	0.00
mature adipocyte, donor4	12234-129G2	17.11	56.85	1.84	1.05	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	37.88	61.71	2.38	0.71	2.38	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	41.74	4.51	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	22.99	20.97	0.92	0.74	0.55	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	25.41	52.74	3.49	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	20.90	15.78	0.00	0.43	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	28.52	27.00	1.69	0.68	0.00	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	29.92	21.86	0.21	1.27	0.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	42.38	50.08	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	42.35	31.23	1.44	3.95	0.36	1.44	0.00
medulla oblongata - adult, donor10196	10174-103C3	12.98	39.59	2.60	0.00	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	23.07	23.07	0.77	0.77	0.77	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	17.47	26.37	0.90	0.57	0.16	0.49	0.00
medulla oblongata, newborn, donor10223	10361-105F1	31.94	33.68	0.69	2.08	0.35	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	20.59	18.82	0.66	0.89	0.44	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	32.65	56.98	2.57	0.98	0.98	1.47	0.00
melanoma cell line:COLO 679	10514-107E1	26.45	34.36	2.30	1.58	0.57	1.58	0.00
melanoma cell line:G-361	10465-106H6	16.29	19.55	0.27	0.54	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	22.61	17.55	0.36	0.54	0.72	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	51.99	63.44	4.41	2.64	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	56.51	51.07	2.59	2.59	0.78	1.56	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.76	19.95	0.92	1.23	0.46	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.81	16.00	0.36	0.55	0.55	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.92	17.81	1.24	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.20	7.45	0.14	0.84	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.23	11.17	0.96	0.96	0.58	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	47.20	27.07	2.78	2.08	0.69	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	37.07	10.64	1.03	1.03	0.51	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.83	11.27	0.58	0.92	0.12	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.18	15.52	0.80	1.59	0.40	0.80	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.58	12.69	0.81	0.95	0.14	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.04	10.81	0.71	1.28	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.67	19.76	0.66	0.99	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.90	19.37	1.25	1.66	0.42	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.18	13.96	0.35	2.09	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.85	6.53	0.61	1.02	0.82	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.72	15.82	1.44	3.24	1.08	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.10	8.69	0.52	1.34	0.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.50	13.91	0.46	0.00	0.23	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.91	6.71	0.42	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.09	11.21	0.90	1.64	0.60	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.87	12.60	0.61	0.88	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	41.60	12.52	0.00	1.47	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	19.17	12.02	0.57	1.14	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	55.99	21.89	0.00	4.63	0.84	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.99	27.40	0.91	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	31.46	22.76	1.02	1.28	0.00	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	33.50	23.03	1.31	0.52	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	30.81	0.31	1.85	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.83	32.24	0.71	2.12	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.86	22.68	1.35	1.02	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	34.58	25.94	0.39	1.57	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.80	27.80	0.93	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.32	36.34	0.87	0.87	0.29	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.11	29.23	0.45	1.34	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.32	29.32	0.96	1.92	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	22.73	0.73	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.22	27.86	1.01	2.01	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	29.48	35.21	0.41	2.05	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	35.22	30.93	1.72	2.58	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	57.42	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	30.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	42.87	33.13	1.62	1.30	0.97	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	29.10	42.19	5.82	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	50.64	52.77	2.13	2.13	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	43.34	26.99	2.45	4.09	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.04	43.15	1.94	2.33	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	37.78	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	44.71	39.74	2.98	1.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	57.21	4.77	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	33.21	32.02	2.96	1.19	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	37.77	35.34	1.22	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.27	50.04	3.80	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.35	37.59	0.34	1.72	1.03	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	23.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	51.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	17.22	6.89	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.04	37.49	1.63	1.63	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.13	37.34	0.79	1.59	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	29.48	28.30	1.18	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	34.29	33.04	0.62	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	41.44	1.34	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	33.11	21.29	0.00	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	30.82	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	42.68	28.22	0.69	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.90	62.84	3.96	2.47	1.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	52.71	2.24	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.34	57.88	4.45	1.91	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	85.43	91.48	9.67	5.24	3.63	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	78.50	111.21	4.36	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	91.23	100.10	6.34	1.27	1.27	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.37	71.61	5.46	1.21	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	49.71	9.04	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	63.42	75.78	4.12	1.65	4.94	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.00	45.64	3.57	1.98	1.39	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	46.40	39.26	1.95	1.62	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	32.60	4.07	1.02	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	10.06	0.77	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.50	27.64	0.47	0.94	0.71	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	21.78	31.51	1.39	0.70	0.70	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	45.31	58.67	2.67	1.34	0.72	1.34	0.00
mesothelioma cell line:Mero-25	10850-111F4	32.68	114.84	8.85	0.91	0.68	4.09	0.00
mesothelioma cell line:Mero-41	10851-111F5	29.09	37.40	1.22	1.96	0.73	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	40.96	63.77	3.32	2.21	0.66	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	10.51	30.75	1.84	0.00	0.26	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	30.98	30.64	2.04	0.34	0.34	1.02	0.00
mesothelioma cell line:Mero-84	10855-111F9	23.00	25.53	1.77	1.26	1.77	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	51.35	80.75	3.73	1.86	0.41	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	23.85	16.73	0.66	1.99	0.33	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	11.76	13.76	0.54	0.72	0.18	0.72	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	27.33	24.77	0.51	0.85	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	37.41	32.57	2.04	0.51	0.51	0.51	0.00
mesothelioma cell line:No36	10857-111G2	38.82	50.56	0.98	2.94	0.65	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	39.83	36.85	1.35	0.81	1.08	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	27.25	9.02	0.58	1.54	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	23.93	13.07	0.61	0.73	0.37	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	45.23	24.59	0.72	1.44	0.18	0.00	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	34.28	43.10	0.98	1.31	0.65	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	35.39	40.06	3.39	1.91	0.64	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	9.68	14.97	1.61	0.00	0.46	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.02	31.59	1.71	0.95	0.00	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	101.08	45.64	1.66	4.62	0.74	0.18	0.00
myeloma cell line:PCM6	10474-106I6	23.92	132.24	3.56	0.20	0.79	1.38	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.32	23.34	0.51	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.08	19.03	2.16	2.75	1.77	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.91	40.00	2.01	0.56	0.45	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.93	46.99	2.06	0.44	0.15	0.51	0.00
nasal epithelial cells, donor2	12227-129F4	10.49	21.53	2.76	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	48.08	86.04	3.91	1.38	1.15	2.30	0.00
neuroblastoma cell line:NB-1	10539-107G8	41.91	26.38	0.75	2.62	0.19	1.12	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	52.09	48.72	2.11	1.27	0.84	2.53	0.00
neuroblastoma cell line:NH-12	10555-107I6	57.40	31.87	0.75	1.12	0.93	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	63.10	12.81	0.71	3.32	0.47	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	100.57	26.45	1.43	6.81	1.27	1.27	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	49.31	37.23	1.61	1.21	0.00	1.41	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	43.87	6.99	0.00	3.18	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.56	25.29	1.06	2.13	0.53	0.27	0.00
neutrophil PMN, donor1	12133-128D9	44.62	44.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	26.56	0.00	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	123.12	56.82	0.00	9.47	0.00	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	18.43	8.79	1.18	0.68	0.17	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	110.47	81.65	0.80	3.20	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	42.32	22.12	3.85	1.60	1.28	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	47.30	30.74	0.79	0.79	1.58	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	25.68	20.81	1.59	0.66	0.28	1.03	0.00
occipital cortex - adult, donor10196	10172-103C1	16.48	16.48	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	28.18	16.37	1.07	0.54	0.27	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	50.22	24.75	1.82	1.46	0.36	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	66.12	37.00	2.36	2.10	1.05	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	46.34	41.62	2.15	6.01	0.00	0.86	0.00
occipital pole, adult, pool1	10036-101E9	31.06	25.94	1.50	1.26	0.08	1.18	0.00
olfactory region, adult	10195-103E6	23.50	24.65	1.34	0.76	0.57	1.72	0.00
optic nerve, donor1	10277-104E7	42.02	56.03	14.01	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	29.50	29.16	1.25	0.80	0.46	1.59	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.01	12.91	1.24	0.69	0.14	0.55	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	22.35	24.38	0.51	0.51	1.02	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	14.67	42.85	3.93	0.46	0.92	0.46	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	23.81	20.87	1.47	1.18	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.05	30.83	1.87	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.14	16.33	0.85	1.06	0.42	0.64	0.00
ovary, adult, pool1	10020-101D2	22.36	27.78	0.79	1.22	0.09	0.44	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.30	32.81	0.73	1.47	2.02	0.55	0.00
pancreas, adult, donor1	10049-101G4	30.10	32.92	1.88	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	42.21	19.85	0.56	0.56	0.56	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	34.07	54.17	0.68	0.34	0.51	1.87	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.84	11.59	0.33	0.17	0.17	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	25.17	22.24	0.92	1.10	0.27	1.10	0.00
parietal cortex, adult, donor10258	10373-105G4	20.55	24.96	1.47	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	31.98	3.76	2.82	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	25.37	20.24	0.86	1.14	0.29	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	21.85	21.06	1.32	1.76	0.26	1.15	0.00
parietal lobe, fetal, donor1	10072-101I9	47.52	30.06	2.91	5.82	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	40.00	23.18	0.37	2.99	0.75	0.37	0.00
parotid gland, adult	10199-103F1	35.77	44.40	0.00	0.62	3.08	0.62	0.00
penis, adult	10200-103F2	20.95	20.95	1.07	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	42.58	26.77	0.93	2.23	0.56	0.74	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.38	46.48	1.17	0.29	1.60	1.46	0.00
pineal gland - adult, donor10196	10179-103C8	26.45	21.29	2.58	1.29	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	24.87	6.51	0.00	1.18	0.59	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	26.96	18.19	0.63	1.25	1.25	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	22.26	35.41	4.05	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	34.92	22.41	1.56	1.56	1.04	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	34.90	35.75	4.26	0.85	0.00	1.70	0.00
placenta, adult, pool1	10021-101D3	20.21	20.00	1.61	0.75	0.22	0.65	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	10.73	23.17	1.06	0.66	0.79	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	22.10	24.59	0.62	0.93	0.47	0.16	0.00
pons, adult, pool1	10033-101E6	11.79	30.12	1.03	0.52	0.26	0.69	0.00
postcentral gyrus, adult, pool1	10032-101E5	34.87	34.70	1.48	1.05	0.26	0.96	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	75.29	4.18	4.18	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	82.62	71.60	11.02	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	164.30	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	19.08	37.58	2.18	1.17	0.73	1.02	0.00
prostate cancer cell line:PC-3	10439-106E7	35.76	30.49	1.09	1.27	1.45	1.27	0.00
prostate, adult, pool1	10022-101D4	26.66	19.95	1.27	1.27	0.27	0.45	0.00
putamen, adult, donor10196	10176-103C5	30.69	34.47	0.71	0.24	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	27.45	47.06	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	24.04	2.19	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	24.40	35.03	2.66	0.48	0.24	1.21	0.00
putamen, newborn, donor10223	10365-105F5	36.73	11.99	0.00	0.75	0.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	13.96	27.06	0.87	0.29	0.29	0.87	0.00
rectum, fetal, donor1	10067-101I4	27.82	15.30	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.86	37.74	1.06	1.48	0.00	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.33	39.35	1.66	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	26.64	38.07	0.99	0.70	0.30	0.50	0.00
retinoblastoma cell line:Y79	10475-106I7	11.69	30.66	2.34	0.26	0.52	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.73	17.09	0.25	0.12	0.25	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	24.18	10.40	0.00	1.69	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	44.71	35.62	0.76	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	10.52	18.13	0.49	0.32	0.16	0.16	0.00
salivary acinar cells, donor2	11772-123I8	11.29	20.93	1.10	0.41	0.69	0.83	0.00
salivary acinar cells, donor3	11773-123I9	15.23	43.70	0.66	0.66	1.32	1.32	0.00
salivary gland, adult, pool1	10093-102C3	36.60	41.18	0.57	1.14	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.66	15.01	0.76	0.84	0.25	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.69	16.10	0.12	0.82	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	29.10	48.67	1.06	1.06	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.00	29.39	0.73	0.49	0.49	1.46	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	68.70	87.32	5.28	3.27	2.52	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	63.22	38.13	1.00	8.03	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	50.77	47.55	3.22	2.01	1.21	1.75	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	23.76	62.23	2.43	0.44	0.44	1.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.81	14.06	0.90	0.65	0.00	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	38.30	70.22	2.84	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	35.38	53.61	2.88	1.44	0.24	0.84	0.00
skeletal muscle, fetal, donor1	10066-101I3	41.21	23.12	1.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	33.93	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	30.30	20.20	0.63	1.89	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.71	67.04	3.34	1.33	1.00	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	80.06	54.22	4.10	1.58	8.51	6.30	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	70.93	30.26	1.73	2.89	0.39	1.35	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	16.15	38.24	0.99	0.49	1.98	1.48	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.11	20.11	0.97	1.29	0.64	1.13	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	20.48	98.06	4.14	0.44	2.62	0.44	0.00
small intestine, adult, pool1	10024-101D6	31.77	52.44	2.51	0.72	0.72	0.60	0.00
small intestine, fetal, donor1	10064-101I1	27.27	31.45	1.47	1.97	0.25	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	66.68	113.35	2.56	2.56	1.54	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	23.00	13.18	0.26	0.26	0.00	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	15.55	29.21	0.54	1.07	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	15.37	29.36	1.15	0.69	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	16.17	16.17	1.58	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	13.14	20.06	1.38	2.77	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	48.18	39.03	1.22	2.44	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	17.91	18.83	0.46	1.38	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.92	17.47	0.60	0.45	0.75	0.45	0.00
spleen, adult, pool1	10025-101D7	34.36	17.62	0.99	0.77	0.44	0.22	0.00
spleen, fetal, pool1	10044-101F8	35.36	13.19	0.79	0.87	0.40	0.08	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	9.83	13.66	0.21	0.93	0.31	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.20	7.03	0.57	0.19	0.19	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	31.10	19.92	1.05	1.05	0.35	2.10	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	42.22	81.70	5.08	0.39	1.17	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.27	66.63	4.50	2.81	0.56	1.24	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	46.60	59.73	2.12	1.69	1.27	2.54	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	17.77	12.27	0.42	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	36.31	67.28	3.20	1.07	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	31.90	42.16	1.14	2.85	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.52	22.22	0.83	0.62	0.00	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	19.14	51.73	2.07	0.52	1.03	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	38.16	32.50	0.00	0.00	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	51.58	20.40	0.69	2.06	0.23	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	46.37	35.35	1.70	2.12	0.51	1.44	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	66.24	37.75	2.14	7.12	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.50	38.24	3.08	5.71	0.44	1.76	0.00
tenocyte, donor1	11763-123H8	25.14	11.87	1.75	0.70	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	38.53	33.57	0.76	1.14	1.91	0.00	0.00
tenocyte, donor3	11768-123I4	38.55	23.72	0.74	1.11	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.64	12.41	1.02	1.36	0.00	1.19	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	49.17	26.05	1.70	2.16	0.92	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	32.08	8.06	0.77	1.70	1.55	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.81	23.99	2.29	0.76	1.65	1.78	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	22.31	21.56	1.89	0.38	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.23	22.79	1.31	1.53	0.87	0.98	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	26.38	17.26	0.00	0.65	0.00	1.63	0.00
testis, adult, pool1	10026-101D8	47.24	42.41	6.87	1.93	0.64	0.97	0.00
testis, adult, pool2	10096-102C6	50.97	37.89	8.57	2.71	1.35	0.00	0.00
thalamus - adult, donor10196	10168-103B6	19.87	36.43	0.00	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	23.75	23.29	1.25	0.31	0.78	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	69.28	6.16	3.08	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.14	68.68	3.29	0.99	0.82	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	29.34	48.90	0.58	2.88	0.58	0.00	0.00
throat, adult	10209-103G2	20.97	32.21	2.25	1.25	0.50	0.00	0.00
throat, fetal, donor1	10061-101H7	30.47	30.47	0.61	2.13	0.61	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	54.45	20.67	1.19	2.38	0.20	1.19	0.00
thymus, adult, pool1	10027-101D9	59.35	39.27	0.99	1.49	0.20	0.50	0.00
thymus, fetal, pool1	10043-101F7	31.28	23.59	0.83	1.25	0.10	0.73	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.49	41.35	0.93	0.93	0.93	0.40	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	42.89	62.16	1.96	1.82	1.54	0.70	0.00
thyroid, adult, pool1	10028-101E1	27.25	52.54	1.68	0.84	0.37	0.75	0.00
thyroid, fetal, donor1	10060-101H6	29.79	40.87	1.05	0.26	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	36.96	6.16	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	24.65	36.28	0.93	0.93	0.23	0.00	0.00
tongue, fetal, donor1	10059-101H5	28.37	24.83	3.55	1.58	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	24.04	27.55	1.00	0.60	0.00	0.70	0.00
trachea, adult, pool1	10029-101E2	27.32	18.81	1.39	0.90	0.65	0.57	0.00
trachea, fetal, donor1	10058-101H4	41.16	23.47	2.69	1.54	0.77	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.99	25.51	1.77	3.54	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	14.59	25.33	0.81	0.51	0.30	1.22	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.85	13.48	0.47	1.10	0.63	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	34.25	49.47	1.90	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	55.78	36.82	1.35	1.69	0.59	1.02	0.00
umbilical cord, fetal, donor1	10057-101H3	31.30	14.61	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	27.81	23.89	1.02	1.19	0.17	0.17	0.00
uterus, fetal, donor1	10055-101H1	32.76	22.52	1.54	0.51	0.00	0.00	0.00
vagina, adult	10204-103F6	31.02	8.40	0.00	2.58	0.00	0.00	0.00
vein, adult	10191-103E2	27.62	25.87	1.75	1.53	0.22	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.68	25.37	0.80	0.27	0.53	0.27	0.00